Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Arthritis Rheumatol. 2019 Feb 28;71(4):496–506. doi: 10.1002/art.40771

Figure 4. Global Myocardial 18F-FDG Uptake Before and After Acceleration of Therapy Compared with non-RA Controls.

Figure 4.

Means and 95% confidence intervals are depicted. Controls had only one scan while rheumatoid arthritis patients had a scan before (T1) and after 6-months (T2) of step-up therapy with either TNF-inhibitors or triple therapy with sulfasalazine and hydroxychloroquine on a background of methotrexate.